Thrombotic Microangiopathy in Patients Recovering from COVID-19

2Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

INTRODUCTION During the pandemic caused by the SARSCoV-2 virus, some patients who develop severe forms of COVID-19 present thrombotic microangiopathy in the course of the disease’s clinical progression. METHODS Data came from direct patient observation and clinical records. We performed a kidney biopsy and used optical microscopy and immunofluorescence techniques. RESULTS We present the case of a 78-year-old male patient, mestizo, overweight with a history of high blood pressure, ischemic cardiopathy and chronic obstructive pulmonary disease who was first admitted to the hospital due to respiratory symptoms and diarrhea related to COVID-19, from which he recovered. He was subsequently readmitted with symptoms of acute renal dysfunction accompanied by mild anemia and thrombocytopenia; at the same time, he resulted negative for COVID-19 via a real-time polymerase chain reaction test. A kidney biopsy revealed thrombi in glomerular capillaries, acute tubular necrosis, thickening of extraglomerular blood vessel walls, and C3 deposits in the glomerular tufts. CONCLUSIONS We describe a case of thrombotic microangiopathy with kidney biopsy in a patient recovering from COVID-19. Acute renal dysfunction is a form of thrombotic microangiopathy that has been observed in patients recovering from COVID-19.

Cite

CITATION STYLE

APA

López-Marín, L., Bacallao-Méndez, R. A., Llerena-Ferrer, B., Badell-Moore, A., García-Villar, Y., Rodríguez-Leyva, L., & Herrera-Valdés, R. (2022). Thrombotic Microangiopathy in Patients Recovering from COVID-19. MEDICC Review, 24(1), 32–35. https://doi.org/10.37757/MR2022.V24.N1.2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free